Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel
NDC Package 69693-003-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel gel is use for the temporary relief of pain. This formulation utilizes a gel delivery system. Marketed by Clarion Brands Llc, this product is identified by NDC 69693-003 and is authorized under FDA application M017.

Identification & Billing

NDC Package Code
69693-003-03
Package Description
1 mL in 1 BOTTLE, PLASTIC
Product Code
69693-003
11-Digit Billing Format
69693000303
RxNorm Crosswalk
  • RxCUI: 2727302 - benzyl alcohol 10 % / lidocaine hydrochloride 4 % Topical Gel
  • RxCUI: 2727302 - benzyl alcohol 0.1 ML/ML / lidocaine hydrochloride 0.04 MG/MG Topical Gel

Clinical Specifications

Proprietary Name
Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel
Non-Proprietary Name
Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel
Substance Name
Benzyl Alcohol; Lidocaine Hydrochloride
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Use for the temporary relief of pain

Regulatory & Marketing

Labeler Name
Clarion Brands Llc
Product Type
Human Otc Drug
FDA Application #
M017
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
11-15-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69693-003-03 identifies a specific commercial package of 1 ml in 1 bottle, plastic of Thermacare Heat Therapy Max Strength Lidocaine Pain Relief Gel, a human over the counter drug labeled by Clarion Brands Llc. This gel is formulated for topical use and contains benzyl alcohol; lidocaine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Clarion Brands Llc on November 15, 2025. The current certification is valid through December 31, 2026.

How is this Clarion Brands Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69693000303. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69693-003-03
11-Digit CMS (5-4-2)
69693-0003-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.